 New York, NY, and Tel Aviv, ISRAEL, May 27, 2022 GLOBE NEWSWIRE -- via NewMediaWire -- Todos Medical, Ltd. OTCQB: TOMDF, a comprehensive medical diagnostics and related solutions company, today announced that majority-owned subsidiary 3CL Pharma will present final data from the phase 2 clinical trial of TollovirTM in the treatment of hospitalized severe and critical COVID-19 patients at the Personalized Medicine World Conference PMWC on June 30th, 2022 at 1:30pm Pacific Time. 